Navignostics Company

Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey.

At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancer drug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development.

Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners.

This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.


Connections

Total Funding: 8658516
Founded Date: 2022-04-01
Industry: Quantum Biology
Employee Number: 11-50
Last Funding Date: 2022-11-09
Funding Status: private
Headquarters: Zürich,Zurich,Switzerland,Europe
Super Industry: Quantum Science Applications
Funding Stage: Seed
Funding Total Value: 8500000
Last Funding Total Usd: 7624780
Last Funding Total Currency: CHF
Last Funding Total Value: 7500000
Founders: Andrea Jacobs,Dr. Jana Fischer,Dr. Stéphane Chevrier,Prof. Bernd Bodenmiller
Phone Number: +41 44 635 66 30